Free Trial

Moderna (MRNA) SEC Filings & 10K Form

Moderna logo
$40.03 -0.73 (-1.79%)
(As of 09:58 AM ET)

Recent Moderna SEC Filings

DateFilerForm TypeView
12/09/2024
2:18 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2024
3:51 PM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
3:55 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
2:23 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2024
3:26 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2024
3:15 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2024
3:19 PM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2024
2:49 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/29/2024
2:54 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/29/2024
2:35 PM
Mock James M (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/07/2024
5:33 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2024
3:19 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
7:49 AM
Hussain Abbas (Reporting)
Moderna (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/04/2024
7:52 AM
Hussain Abbas (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
6:03 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
5:03 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
3:15 PM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
2:29 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
4:42 PM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
3:26 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
2:42 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/30/2024
3:34 PM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
3:37 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
3:45 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2024
3:30 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2024
3:33 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
3:02 PM
Moderna (Issuer)
Rubenstein David M. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/02/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
5:31 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2024
3:19 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/23/2024
6:05 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:23 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/15/2024
10:44 AM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/12/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2024
3:19 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2024
3:34 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
2:28 PM
Mock James M (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/28/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2024
3:19 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Genesis leading the smart algo revolution? (Ad)

I’m revealing an exciting breakthrough that can help trade the markets unlike anything you’ve ever seen before… Because with my BRAND NEW smart algo you’ll always have a constant stream of alerts firing off in your back pocket to choose from. Here’s why: It does all the heavy lifting for you… automatically. Stock Ticker, Entry Price, Profit Target, Stop Loss, and even an Individual Chart!

You’ll want to see what I’ve put on this page right here
06/21/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
3:28 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
11:45 AM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/14/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
3:20 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/11/2024
6:01 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
4:41 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/11/2024
4:26 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2024
2:16 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:22 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/04/2024
4:27 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
4:20 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
2:36 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2024
2:20 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2024
2:11 PM
Mock James M (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/31/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
3:36 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
3:34 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/29/2024
3:12 PM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
2:12 PM
Mock James M (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/29/2024
2:14 PM
Garay Arpa (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/29/2024
2:20 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/29/2024
2:22 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/28/2024
2:21 PM
Mock James M (Reporting)
Mock James M (Reporting)
Moderna (Subject)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/28/2024
2:21 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/24/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
3:27 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/17/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
3:23 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/15/2024
12:41 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/13/2024
3:03 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
3:43 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/08/2024
3:24 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/07/2024
3:51 PM
LANGER ROBERT (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
3:54 PM
Horning Sandra (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
3:57 PM
Moderna (Issuer)
Tallett Elizabeth E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
3:59 PM
Moderna (Issuer)
SAGAN PAUL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
4:02 PM
Moderna (Issuer)
Nader Francois (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
3:42 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
5:31 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2024
3:21 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/19/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2024
3:17 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/16/2024
3:23 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
9:58 AM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/12/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)

Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.

Click here to watch this demo and decide for yourself.
04/10/2024
3:22 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/10/2024
1:03 PM
Moderna (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
04/09/2024
3:09 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
2:32 PM
Mock James M (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/05/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
3:20 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/29/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
3:22 PM
AFEYAN NOUBAR (Reporting)
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/22/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MRNA) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners